ALLISON KING: Open Payments
NPI 1609027465 · BARTLETT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,595 in 143 payments from 19 companies in 2025. Trend: 2023 $4,723 · 2024 $3,371 · 2025 $2,595
Food & beverage: $2,477Education: $118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $471 |
| Amgen Inc. | 16 | $230 |
| LEO Pharma Inc. | 7 | $225 |
| UCB, Inc. | 14 | $195 |
| Novartis Pharmaceuticals Corporation | 9 | $188 |
| GENZYME CORPORATION | 4 | $183 |
| Galderma Laboratories, L.P. | 10 | $160 |
| Regeneron Healthcare Solutions, Inc. | 5 | $126 |
| Janssen Biotech, Inc. | 6 | $124 |
| E.R. Squibb & Sons, L.L.C. | 7 | $123 |
Products named: SKYRIZI, DUPIXENT, OTEZLA, Bimzelx, ADBRY, NEMLUVIO, COSENTYX, TREMFYA.
Industry payments across TN — which companies pay providers there.
